Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Workflow (Target Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimization, Preclinical Development, Other Associated Workflow), By Therapeutics Area (Respiratory System, Pain and Anesthesia, Oncology, Ophthalmology, Hematology, Cardiovascular, Endocrine, Gastrointestinal, Immunomodulation, Anti-Infective, Central Nervous System, Dermatology, Genitourinary System), By Drug Type (Small Molecules, Large Molecules (Biopharmaceuticals)) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR2942DR | Pages: 110

Market Segmentation

  1. Drug Discovery Outsourcing Market,  By Workflow 2022-2034 (USD MILLION/ Units)
    1. Target Identification & Screening
    2. Target Validation & Functional Informatics
    3. Lead Identification & Candidate Optimization
    4. Preclinical Development
    5. Other Associated Workflow
  2. Drug Discovery Outsourcing Market,  By Therapeutics Area 2022-2034 (USD MILLION/ Units)
    1. Respiratory System
    2. Pain and Anesthesia, Oncology
    3. Ophthalmology
    4. Hematology
    5. Cardiovascular
    6. Endocrine
    7. Gastrointestinal
    8. Immunomodulation
    9. Anti-Infective
    10. Central Nervous System
    11. Dermatology
    12. Genitourinary System
  3. Drug Discovery Outsourcing Market,  By Drug Type 2022-2034 (USD MILLION/ Units)
    1. Small Molecules
    2. Large Molecules (Biopharmaceuticals)
  4. Regional Drug Discovery Outsourcing Market
    1. North America
      1. North America Drug Discovery Outsourcing Market  By Workflow 2022-2034 (USD MILLION/ Units)
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
      2. North America Drug Discovery Outsourcing Market  By Therapeutics Area 2022-2034 (USD MILLION/ Units)
        1. Respiratory System
        2. Pain and Anesthesia, Oncology
        3. Ophthalmology
        4. Hematology
        5. Cardiovascular
        6. Endocrine
        7. Gastrointestinal
        8. Immunomodulation
        9. Anti-Infective
        10. Central Nervous System
        11. Dermatology
        12. Genitourinary System
      3. North America Drug Discovery Outsourcing Market  By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Large Molecules (Biopharmaceuticals)
      4. U.S.
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      5. Canada
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
    2. Europe
      1. Europe Drug Discovery Outsourcing Market  By Workflow 2022-2034 (USD MILLION/ Units)
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
      2. Europe Drug Discovery Outsourcing Market  By Therapeutics Area 2022-2034 (USD MILLION/ Units)
        1. Respiratory System
        2. Pain and Anesthesia, Oncology
        3. Ophthalmology
        4. Hematology
        5. Cardiovascular
        6. Endocrine
        7. Gastrointestinal
        8. Immunomodulation
        9. Anti-Infective
        10. Central Nervous System
        11. Dermatology
        12. Genitourinary System
      3. Europe Drug Discovery Outsourcing Market  By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Large Molecules (Biopharmaceuticals)
      4. U.K.
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      5. Germany
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      6. France
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      7. Spain
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      8. Italy
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      9. Russia
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      10. Nordic
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      11. Benelux
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      12. Rest of Europe
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
    3. APAC
      1. APAC Drug Discovery Outsourcing Market  By Workflow 2022-2034 (USD MILLION/ Units)
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
      2. APAC Drug Discovery Outsourcing Market  By Therapeutics Area 2022-2034 (USD MILLION/ Units)
        1. Respiratory System
        2. Pain and Anesthesia, Oncology
        3. Ophthalmology
        4. Hematology
        5. Cardiovascular
        6. Endocrine
        7. Gastrointestinal
        8. Immunomodulation
        9. Anti-Infective
        10. Central Nervous System
        11. Dermatology
        12. Genitourinary System
      3. APAC Drug Discovery Outsourcing Market  By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Large Molecules (Biopharmaceuticals)
      4. China
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      5. Korea
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      6. Japan
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      7. India
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      8. Australia
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      9. Taiwan
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      10. South East Asia
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      11. Rest of Asia-Pacific
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
    4. Middle East and Africa
      1. Middle East and Africa Drug Discovery Outsourcing Market  By Workflow 2022-2034 (USD MILLION/ Units)
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
      2. Middle East and Africa Drug Discovery Outsourcing Market  By Therapeutics Area 2022-2034 (USD MILLION/ Units)
        1. Respiratory System
        2. Pain and Anesthesia, Oncology
        3. Ophthalmology
        4. Hematology
        5. Cardiovascular
        6. Endocrine
        7. Gastrointestinal
        8. Immunomodulation
        9. Anti-Infective
        10. Central Nervous System
        11. Dermatology
        12. Genitourinary System
      3. Middle East and Africa Drug Discovery Outsourcing Market  By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Large Molecules (Biopharmaceuticals)
      4. UAE
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      5. Turkey
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      6. Saudi Arabia
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      7. South Africa
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      8. Egypt
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      9. Nigeria
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      10. Rest of MEA
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
    5. LATAM
      1. LATAM Drug Discovery Outsourcing Market  By Workflow 2022-2034 (USD MILLION/ Units)
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
      2. LATAM Drug Discovery Outsourcing Market  By Therapeutics Area 2022-2034 (USD MILLION/ Units)
        1. Respiratory System
        2. Pain and Anesthesia, Oncology
        3. Ophthalmology
        4. Hematology
        5. Cardiovascular
        6. Endocrine
        7. Gastrointestinal
        8. Immunomodulation
        9. Anti-Infective
        10. Central Nervous System
        11. Dermatology
        12. Genitourinary System
      3. LATAM Drug Discovery Outsourcing Market  By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Large Molecules (Biopharmaceuticals)
      4. Brazil
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      5. Mexico
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      6. Argentina
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      7. Chile
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      8. Colombia
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
      9. Rest of LATAM
        1. Target Identification & Screening
        2. Target Validation & Functional Informatics
        3. Lead Identification & Candidate Optimization
        4. Preclinical Development
        5. Other Associated Workflow
        6. Respiratory System
        7. Pain and Anesthesia, Oncology
        8. Ophthalmology
        9. Hematology
        10. Cardiovascular
        11. Endocrine
        12. Gastrointestinal
        13. Immunomodulation
        14. Anti-Infective
        15. Central Nervous System
        16. Dermatology
        17. Genitourinary System
        18. Small Molecules
        19. Large Molecules (Biopharmaceuticals)
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: